Keywords: Grumant, Herbal APIs plant, Russia
Russia’n firm Grumant invests $45 million in herbal APIs plant
Article | 25 July 2011
Grumant, one of Russia’s largest manufacturers of pharmaceutical ingredients based on medicinal herbs, plans to invest 1.6 billion roubles ($45 ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- US Supreme Court says patent settlement can "sometimes" be illegal
- Negative US patent ruling for Novo Nordisk on Prandin
- Daiichi Sankyo files for Japanese approval of Prasugrel
- Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
